Polytherapy and Targeted Cancer Drug Resistance
Top Cited Papers
- 26 February 2019
- journal article
- review article
- Published by Elsevier in Trends in Cancer
- Vol. 5 (3), 170-182
- https://doi.org/10.1016/j.trecan.2019.02.003
Abstract
No abstract availableKeywords
This publication has 139 references indexed in Scilit:
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitorsNature, 2012
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretionNature, 2012
- The Origin and Evolution of Mutations in Acute Myeloid LeukemiaCell, 2012
- Genetic heterogeneity and cancer drug resistanceThe Lancet Oncology, 2012
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistanceDrug Resistance Updates, 2012
- FAS and NF-κB signalling modulate dependence of lung cancers on mutant EGFRNature, 2011
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivationNature, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLCCancer Cell, 2010